Literature DB >> 3052809

Immunohistological and functional analyses of lymphoid infiltrates in human glioblastomas.

M C Kuppner1, M F Hamou, N de Tribolet.   

Abstract

An immunohistological analysis of tumor tissue obtained from seven patients with malignant gliomas demonstrated varying levels of lymphoid cell infiltration. The tumor infiltrating lymphocytes obtained from each sample were cultured in vitro by a limiting dilution technique. In three of the cases studied many tumor infiltrating lymphocyte microcultures selectively lysed autologous glioblastoma cells but did not lyse allogeneic gliomas, natural killer-resistant fresh melanoma cells or K562 target cells. These cultures were found to consist of CD 3+ cells. In six cases studied a variable number of microcultures lysed both autologous tumor and K562 target cells only. A minority of the microcultures studied were cytolytic for allogeneic glioma cells and fresh melanoma target cells. The cytolytic activity expressed by tumor infiltrating lymphocytes against autologous tumor cells was significantly greater (P less than 0.001) than that obtained by the corresponding peripheral blood lymphocytes cultured in a similar manner. The present immunohistological and functional studies suggest that there is an immune response to human glioblastomas in vivo with an accumulation of cells with antitumor activity at the tumor site.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3052809

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival.

Authors:  Isaac Yang; Tarik Tihan; Seunggu J Han; Margaret R Wrensch; John Wiencke; Michael E Sughrue; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2010-08-19       Impact factor: 1.961

2.  Tumour infiltrating lymphocytes: insights into tumour immunology and potential therapeutic implications.

Authors:  K F Yoong; D H Adams
Journal:  Clin Mol Pathol       Date:  1996-10

3.  Alteration in interactions between tumor-infiltrating lymphocytes and tumor cells in human melanomas after chemotherapy or immunotherapy.

Authors:  K Itoh; K Hayakawa; M A Salmeron; S S Legha; J L Murray; M Talpaz; C M Balch; D R Parkinson; K Lee; A A Zukiwski
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 4.  The role of the immune system in neurofibromatosis type 1-associated nervous system tumors.

Authors:  Souvik Karmakar; Karlyne M Reilly
Journal:  CNS Oncol       Date:  2016-12-21

5.  Phenotypic characteristics of tumour-infiltrating lymphocytes in human oesophageal cancer tissues defined by quantitative two-colour analysis with flow-cytometry.

Authors:  H Tahara; H Shiozaki; K Kobayashi; T Yano; H Yano; S Tamura; K Oku; M Miyata; K Wakasa; M Sakurai
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

6.  Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype.

Authors:  E A Grimm; J M Bruner; J Carinhas; J A Köppen; W G Loudon; L Owen-Schaub; P A Steck; R P Moser
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

7.  Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors.

Authors:  L H Elliott; W H Brooks; T L Roszman
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

8.  Enhancement of the lytic activity of cloned human CD8 tumour-infiltrating lymphocytes by bispecific monoclonal antibodies.

Authors:  A Gorter; K M Krüse; P I Schrier; G J Fleuren; R J van de Griend
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

9.  Human glioblastoma cells produce 77 amino acid interleukin-8 (IL-8(77)).

Authors:  M Tada; K Suzuki; Y Yamakawa; Y Sawamura; S Sakuma; H Abe; E van Meir; N de Tribolet
Journal:  J Neurooncol       Date:  1993-04       Impact factor: 4.130

10.  Cross-reactivity of monoclonal antibody Leu-19 with some neuroectodermal and other non-immune tissues.

Authors:  R Nawrotzki; A Starzinski-Powitz; F Weber; R Schröder
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.